Show source-provided references
1. Inflammation: roles in skeletal muscle atrophy
2. PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways
10.21037/atm.2019.08.101 ↗3. Salidroside attenuates denervation-induced skeletal muscle atrophy through negative regulation of pro-inflammatory cytokine
10.3389/fphys.2019.00665 ↗4. SKP-SC-EVs mitigate denervated muscle atrophy by inhibiting oxidative stress and inflammation and improving microcirculation
5. Isoquercitrin delays denervated soleus muscle atrophy by inhibiting oxidative stress and inflammation
10.3389/fphys.2020.00988 ↗6. Mechanistic role of reactive oxygen species and therapeutic potential of antioxidants in denervation- or fasting-induced skeletal muscle atrophy
10.3389/fphys.2018.00215 ↗7. Celecoxib alleviates denervation-induced muscle atrophy by suppressing inflammation and oxidative stress and improving microcirculation
10.1016/j.bcp.2022.115186 ↗9. Single-cell RNA-seq reveals novel interaction between muscle satellite cells and fibro-adipogenic progenitors mediated with FGF7 signalling
10.1002/jcsm.13484 ↗16. Potential therapeutic strategies for skeletal muscle atrophy
18. Decellularized extracellular matrix-based composite scaffolds for tissue engineering and regenerative medicine
10.1093/rb/rbad107 ↗23. Nano-biomaterials and advanced fabrication techniques for engineering skeletal muscle tissue constructs in regenerative medicine
10.1186/s40580-023-00398-y ↗25. Antioxidant and anti-inflammatory injectable hydrogel microspheres for in situ treatment of tendinopathy
10.1093/rb/rbae007 ↗26. 3D human induced pluripotent stem cell-derived bioengineered skeletal muscles for tissue, disease and therapy modeling
10.1038/s41596-022-00790-8 ↗28. Highly contractile 3D tissue engineered skeletal muscles from human iPSCs reveal similarities with primary myoblast-derived tissues
10.1016/j.stemcr.2023.08.014 ↗30. Isolating myofibrils from skeletal muscle biopsies and determining contractile function with a nano-Newton resolution force transducer
10.3791/61002 ↗31. Biochemical and structural basis of the passive mechanical properties of whole skeletal muscle
10.1113/JP280867 ↗34. The myonuclear domain in adult skeletal muscle fibres: past, present and future
10.1113/JP283658 ↗36. Skeletal muscle: a review of molecular structure and function, in health and disease
10.1002/wsbm.1462 ↗38. Adenosine monophosphate activated protein kinase contributes to skeletal muscle health through the control of mitochondrial function
10.3389/fphar.2022.947387 ↗39. Transplantation of allogeneic PW1(pos)/Pax7(neg) interstitial cells enhance endogenous repair of injured porcine skeletal muscle
10.1016/j.jacbts.2017.08.002 ↗40. Development of a cell-free strategy to recover aged skeletal muscle after disuse
10.1113/JP282867 ↗41. Human skeletal muscle-derived CD133(+) cells form functional satellite cells after intramuscular transplantation in immunodeficient host mice
10.1038/mt.2014.26 ↗44. Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models
10.1002/jcsm.13103 ↗46. CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function
10.1073/pnas.1813351116 ↗47. Dependence of thick filament structure in relaxed mammalian skeletal muscle on temperature and interfilament spacing
10.1085/jgp.202012713 ↗48. Dependence of myosin filament structure on intracellular calcium concentration in skeletal muscle
10.1085/jgp.202313393 ↗51. Thick filament activation is different in fast- and slow-twitch skeletal muscle
10.1113/JP283574 ↗52. Targeting the DP2 receptor alleviates muscle atrophy and diet-induced obesity in mice through oxidative myofiber transition
10.1002/jcsm.13136 ↗54. Celecoxib attenuates hindlimb unloading-induced muscle atrophy via suppressing inflammation, oxidative stress and ER stress by inhibiting STAT3
10.1007/s10787-024-01454-7 ↗55. Skeletal muscle fiber type in hypoxia: adaptation to High-Altitude exposure and under conditions of pathological hypoxia
10.3389/fphys.2018.01450 ↗56. Effects of protocatechuic acid on antioxidant capacity, mitochondrial biogenesis and skeletal muscle fiber transformation
10.1016/j.jnutbio.2023.109327 ↗59. An overview of the role of neutrophils in innate immunity, inflammation and host-biomaterial integration
10.1093/rb/rbw041 ↗64. p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair
10.1083/jcb.201104053 ↗65. Skeletal muscle regeneration failure in ischemic-damaged limbs is associated with pro-inflammatory macrophages and premature differentiation of satellite cells
10.1186/s13073-023-01250-y ↗67. Role of macrophages during skeletal muscle regeneration and hypertrophy-implications for immunomodulatory strategies
10.14814/phy2.15480 ↗70. Transcription regulation of Tceal7 by the triple complex of Mef2c, Creb1 and Myod
75. Craniomaxillofacial derived bone marrow mesenchymal stem/stromal cells (BMSCs) for craniomaxillofacial bone tissue engineering: a literature review
10.1016/j.jormas.2022.06.002 ↗78. Protocols for the preparation and characterization of decellularized tissue and organ scaffolds for tissue engineering
10.2144/btn-2020-0141 ↗79. Skeletal Muscle-Derived human mesenchymal stem cells: influence of different culture conditions on proliferative and myogenic capabilities
10.3389/fphys.2020.553198 ↗80. Skeletal muscle regeneration via the chemical induction and expansion of myogenic stem cells in situ or in vitro
10.1038/s41551-021-00696-y ↗82. Co-delivery of fibrin-laminin hydrogel with mesenchymal stem cell spheroids supports skeletal muscle regeneration following trauma
10.1002/term.3243 ↗85. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration
10.1007/s00441-018-2792-3 ↗86. Tetramethylpyrazine induces the release of BDNF from BM-MSCs through activation of the PI3K/AKT/CREB pathway
10.1002/cbin.11687 ↗88. Long-term effectiveness of local BM-MSCs for skeletal muscle regeneration: a proof of concept obtained on a pig model of severe radiation burn
10.1186/s13287-018-1051-6 ↗89. Long-term contribution of human bone marrow mesenchymal stromal cells to skeletal muscle regeneration in mice
10.3727/096368910X522117 ↗90. Hypoxia preconditioned bone marrow-derived mesenchymal stromal/stem cells enhance myoblast fusion and skeletal muscle regeneration
10.1186/s13287-021-02530-3 ↗91. ADSC-based cell therapies for musculoskeletal disorders: a review of recent clinical trials
10.3390/ijms221910586 ↗95. Human ADSC xenograft through IL-6 secretion activates M2 macrophages responsible for the repair of damaged muscle tissue
10.1186/s13287-019-1188-y ↗96. MYOD mediates skeletal myogenic differentiation of human amniotic fluid stem cells and regeneration of muscle injury
10.1186/scrt358 ↗97. Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, smn(F7/F7) mouse model
10.1002/stem.1134 ↗99. Human neuromuscular junction on a chip: impact of amniotic fluid stem cell extracellular vesicles on muscle atrophy and NMJ integrity
10.3390/ijms24054944 ↗